Logo

ArcherDx

Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M

IDT has acquired the VariantPlex, FusionPlex, LiquidPlex, and Immunoverse panels, powered by Invitae's anchored multiplex PCR (AMP) technology.

Repeat Biomarker Testing Informs Next Steps for Treatment-Resistant EGFR-Mutant NSCLC Patients
Premium

Studies at ESMO showed the importance of repeat biomarker testing to guide treatment after resistance to AstraZeneca's Tagrisso, but tissue-based testing remains a hindrance. 

Jury Awards ArcherDx, MGH $4.7M in Qiagen Patent Infringement Lawsuit

A federal jury ruled that various Qiagen sample prep products infringe a pair of US patents underlying ArcherDx's anchored multiplex PCR technology.

M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020
Premium

Although the total number of deals went down in 2020, those deals were worth more compared to 2019 — four of the top five had billion-dollar price tags.

Invitae Q3 Revenues Increase 22 Percent

The firm generated $68.7 million in revenues compared to $56.5 million in Q3 2019 and exceeded the consensus Wall Street estimate. 

Oct 7, 2020

Natera Sues Genosity for Patent Infringement Relating to ArcherDx Products

Oct 5, 2020

Federal Court Rejects ArcherDx Motion Against Natera in Patent Infringement Lawsuit

Oct 5, 2020

Invitae Completes Acquisition of ArcherDx

Aug 7, 2020

Natera Files Additional Patent Infringement Lawsuit Against ArcherDx

Jul 1, 2020

Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index

Jun 22, 2020

Invitae, ArcherDx Ink $1.4B Merger to Advance Precision Oncology Offerings

Jun 18, 2020

ArcherDx, Bristol Myers Squibb Partner on Minimal Residual Disease Monitoring

Jun 7, 2020

ArcherDx Targeting $100M in IPO

May 26, 2020

AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

May 14, 2020

ArcherDx, Bayer Partner on NGS-Based Companion Diagnostic Test Development

Apr 21, 2020

ArcherDx, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers

Apr 15, 2020

Natera Expands IP Lawsuit Against ArcherDx With Three New Patents

Mar 25, 2020

Japanese Regulators Approve Merck KGaA MET Inhibitor With ArcherDx CDx

Jan 27, 2020

Natera Sues ArcherDx for Infringement of New Target Amplification Patent

Jan 10, 2020

ArcherDx, Illumina Agree to Comarket Future IVDs

Dec 17, 2019

ArcherDx Closes $55M Series C Financing

Dec 3, 2019

Illumina, ArcherDx Expand Partnership on NGS IVD Tests

Jul 8, 2019

Ayala, ArcherDx Partner to Advance CDx for Notch Inhibitors

May 24, 2019

Multi-Site Study Tests Power of Commercial Reference Materials in Comparing Liquid Biopsy Assays
Premium

May 15, 2019

ArcherDx Raises $60M in Series B Financing Round

Breaking News
The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.